Doxil

Rediff.com » News » Doxil

News for Doxil

Business

Stocks that shine year after year

Eicher, Sun, Vakrangee, Astral and Wabco are among those beating benchmark indices each year since 2010 and are likely to see strong earnings growth in the next two years as well. The S&P BSE......

IT, pharma rally expected to continue

Notwithstanding a strong run by the S&P BSE Information Technology (up 60 per cent) and S&P BSE Healthcare (up 22 per cent) indices in 2013, most brokerages are still positive on these two sectors......

Strong US growth to boost pharm cos' fortune in FY14

Sun, Lupin and Dr Reddy’s to lead here, with domestic formulations expected to rebound after Sept quarter. After posting a strong 20-plus per cent growth in the March quarter, top Indian......

Sensex falls 91 pts to 1-mth low

Extending losses for the fourth straight day, the BSE benchmark Sensex on Tuesday fell by over 91 points to end at one-month low level of 19,659.82 due to selling in ITC, RIL and ICICI Bank amid......

Sun Pharma gets USFDA nod for anti-cancer injection

Sun Pharmaceutical Industries on Tuesday said it has received US health regulator's approval to market generic version of Doxil injection, used in treating ovarian cancer in the American market.......

Rediff News

Doxil

News for Doxil

Stocks that shine year after year

IT, pharma rally expected to continue

Strong US growth to boost pharm cos' fortune in FY14

Sensex falls 91 pts to 1-mth low

Sun Pharma gets USFDA nod for anti-cancer injection

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS